Tuesday, June 6, 2017
- 1:45pm-3:15pm
-
Saccadic impairment in patients with Gaucher’s disease type 3
Rare Genetic and Metabolic Diseases · Exhibit Hall C
- 1:45pm-3:15pm
-
Salivary Alpha-Synuclein in Aging
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Salivary biomarkers for Huntington’s disease (HD)
Huntington's Disease · Exhibit Hall C
- 1:45pm-3:15pm
-
Saving Veterans Time, Miles, and Money: Cost Analysis of Video Telemedicine Evaluation of Deep Brain Stimulation (DBS) candidacy at the VA
Technology · Exhibit Hall C
- 1:45pm-3:15pm
-
Screening of cognitive impairment in Huntington’s disease with the Parkinson’s Disease – Cognitive Rating Scale (PD-CRS)
Huntington's Disease · Exhibit Hall C
- 1:45pm-3:15pm
-
Sensory modulation of postural control in Huntington’s disease
Huntington's Disease · Exhibit Hall C
- 1:45pm-3:15pm
-
Serum lipid profile in Parkinsons disease patients from Southern Spain
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Serum soluble transferrin receptor levels correlate with the Hoehn & Yahr stage of Parkinson disease progression
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Skin nerve phosphorylated α-synuclein deposits in idiopathic REM sleep behavior disorder.
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Social hindrances for diagnosing Huntington’s disease
Huntington's Disease · Exhibit Hall C
- «Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 38
- Next Page»